MIRA
INFORM REPORT
|
Report Date : |
28.11.2007 |
IDENTIFICATION
DETAILS
|
Name : |
ZUELLIG & WOO (HK) CO LTD |
|
|
|
|
Registered Office : |
Suite 608, 6FL Taikoo Place - Devon House, 979 King's Rd
Quarry Bay |
|
|
|
|
Country : |
Hong Kong |
|
|
|
|
Date of Incorporation : |
August 26, 1993 |
|
|
|
|
Com. Reg. No.: |
0446982 |
|
|
|
|
Legal Form : |
Private |
|
|
|
|
Line of Business : |
Trading various range of pharmaceutical products. |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
Up To USD 150,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
name & address
ZUELLIG & WOO (HK) CO LTD
SUITE 608, 6FL TAIKOO PLACE - DEVON HOUSE
979 KING'S RD QUARRY BAY, HONG KONG.
TEL : 852-28563632
FAX : 852-25907186
EXECUTIVE SUMMARY
INCORPORATION DATE :
AUGUST 26, 1993
REGISTRATION NO. :
0446982
LEGAL FORM :
PRIVATE
CHIEF EXECUTIVE :
N/A
STAFF STRENGTH :
10
CAPITAL :
US$ 3,103,000
BUSINESS LINE :
TRADER
TURNOVER :
N/A (AS OF DEC. 31, 2006)
EQUITIES :
N/A (AS OF DEC. 31, 2006)
PAYMENT :
AVERAGE
RECOMM. CREDIT RANGE : UP TO
USD 150,000
MARKET CONDITION :
AVERAGE
FINANCIAL CONDITION :
N/A
OPERATIONAL TREND : STEADY
GENERAL REPUTATION :
AVERAGE
EXCHANGE RATE :
HKD 7.78198 = US$1
Adopted abbreviations:
ANS - amount not stated
NS - not stated
SC - subject company (the company inquired by you)
NA - not available
M - million
HKD –Hong Kong Dollars
*Company Registration*
==================
(1)
License number : 0446982
Date issued : 26
August, 1993
Issuing authority : Companies
Registry
Type of license : Corporate
License
(2)
License number : 17340671-000
Date issued : N/A
Issuing authority : Business
Registration Office - Inland Revenue Dept
Type of license : Business
License
*Capital Details*
=============
Authorized capital : USD 3,103,000.00 divided into 3,103,000 ordinary
shares at USD 1.00/-each, fully paid
*Office & Facilities*
===============
Other tel no : 25799209
*Reputation*
==========
Reference checking for the purpose of establishing the firm's reputation
within the respective industry failed to reveal any negative information.
*Approved Signatures*
=================
Ms. Elaine June Cheung directors can sign on behalf of the company with
seal affixed.
www.zuelligpharma.com this
web site belongs to “Zuelling Pharma Asia Pacific.”, the design is professional
and the content is well organized. At present it is in English version.
For the past two years there is no record of litigation.
*Major Shareholders*
================
Total number of shareholder : 1
Total number of ordinary shares : 3,103,000
Shareholder's Name
No. of Ordinary Shares
Amount of Shares (USD) % of
Shares
-------------------------- ------------------------------ --------------------------------- ----------------
ZUELLIG & WOO (L) LTD
3,103,000
3,103,000.00
100.00
*Directors' Details*
==============
(1)
Elaine June Cheung
USA passport number : 710540438
Address : Unit 61, 7Fl Middleton
Tower - Block 3 140 Pokfulam Hong Kong
(2)
Fritz Horlacher
Australian passport number : E7059889
Address : 7Fl-B Belgravia Heights 27
Tai Tam Rd Hong Kong
(3)
Mr. James Wing-fai Woo
USA passport number : 711342677
Address :
Flat A 6Fl Borrett Mansion 8 Bowen Rd Hong Kong
*Company Secretary*
================
EQ SECRETARIES LTD
Address : 31Fl The
Center 99 Queen's Rd Central Hong Kong
License number : 99444
SC’s management background details are not available at present.
*Main Products & Services*
=====================
Specializes in trading various range of pharmaceutical products.
Products: Medicines
Pharmaceutical
products
*Payment Terms*
=============
Sales
-------
Local : Cash or credit
Purchases
--------------
Local : Cash or credit
*Local Distribution Network*
=======================
100% of the annual turnover is attributed to local sales.
*Export Markets*
=============
There is no record of export since the prime focus of the firm's
activity is concentrated on local sales only.
*(Subsidiaries, Joint-ventures & Affiliates)
===============================
Company Name : Zuellig Pharma Ltd.
Address : Suite 608, 6Fl Taikoo Place - Devon House 979 King's Rd Quarry
Bay Hong Kong Hong Kong
Country : Hong Kong
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Trader
Industry : Medical Equipment & Pharmaceutical
PAYMENT
RATING : 3 OBTAINED SCORES :
60
|
Implication |
Implications |
|
|
1 |
Scores 85–100 |
Excellent |
|
2 |
Scores 75 – 84 |
Above Average |
|
3 |
Scores 50 – 74 |
Average |
|
4 |
Scores 35 – 49 |
Fair |
|
5 |
Scores 15 – 34 |
Below Average |
|
6 |
Scores 01 – 14 |
Poor |
|
NR |
No Data |
No Data |
The rating indicates the payment
pattern of SC based upon our Payment Database, comments from suppliers of SC,
information from banks (if available), as well as industrial sources.
Dealings on open terms may be possible for SMALL amounts
depending on individual judgement experience.
As a private limited company there is no legal requirement according to
local corporate law for public disclosure of detailed financials.
SC is considered small-sized in its line with a 14 years
development history. Taking into consideration of SC’s general
performance, a credit line up to USD 150,000 would appear to be within SC’s
capacities.
Attached:
trade references
SIC PRODUCT CLASSIFICATION & ACTIVITY
Activity Code Product/Service Description
Trading 2834 Pharmaceutical
preparations
Trading 5122 Drugs/Druggists'
Sundries
HARMONIZED PRODUCT CLASSIFICATION & ACTIVITY
Activity Code Product/Service Description
Trading 2934302700 Other
drugs,
Trading 3000 Pharmaceutical
products
Trading 3003 Medicaments
of mixtures, not dosage etc form
Trading 3004 Medicaments,
mixed or not, in dosage etc form
Trading 3006 Pharmaceutical
goods (specified sterile prod etc.)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)